Bank Of America Corp Cassava Sciences Inc Put Options Transaction History

Bank Of America Corp

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$9.57 - $35.08 $4.59 Million - $16.8 Million	479,600 Added 294.78%	642,300 $18.9 Million
Q2 2024 Aug 14, 2024	BUY	$12.35 - $26.11 $411,255 - $869,463	33,300 Added 25.73%	162,700 $2.01 Million
Q1 2024 May 15, 2024	BUY	$18.44 - $26.41 $335,608 - $480,662	18,200 Added 16.37%	129,400 $2.63 Million
Q4 2023 Feb 14, 2024	SELL	$12.64 - $30.11 $1.12 Million - $2.67 Million	-88,700 Reduced 44.37%	111,200 $2.5 Million
Q1 2023 May 12, 2023	BUY	$23.46 - $36.44 $2.98 Million - $4.63 Million	127,100 Added 174.59%	199,900 $4.82 Million
Q4 2022 Feb 10, 2023	SELL	$27.82 - $44.16 $6.18 Million - $9.81 Million	-222,100 Reduced 75.31%	72,800 $2.15 Million
Q3 2022 Nov 14, 2022	BUY	$16.33 - $51.06 $3.15 Million - $9.85 Million	192,900 Added 189.12%	294,900 $12.3 Million
Q2 2022 Aug 12, 2022	BUY	$17.22 - $38.47 $1.75 Million - $3.92 Million	101,800 Added 50900.0%	102,000 $2.87 Million
Q1 2022 May 16, 2022	SELL	$32.6 - $53.05 $6.51 Million - $10.6 Million	-199,800 Reduced 99.9%	200 $7,000
Q4 2021 Feb 08, 2022	BUY	$36.77 - $90.91 $3.68 Million - $9.09 Million	100,000 Added 100.0%	200,000 $8.74 Million
Q3 2021 Nov 15, 2021	SELL	$41.79 - $135.3 $743,862 - $2.41 Million	-17,800 Reduced 15.11%	100,000 $6.21 Million
Q2 2021 Sep 13, 2021	BUY	$32.15 - $89.72 $3.79 Million - $10.6 Million	117,800 New	117,800 $10.1 Million

207

14M

2.98M

6.57M

Ticker SAVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,097,900
Market Cap $102M
Description
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.